PE20080425A1 - Formulacion aerosol para la inhalacion de beta-agonistas - Google Patents
Formulacion aerosol para la inhalacion de beta-agonistasInfo
- Publication number
- PE20080425A1 PE20080425A1 PE2007001122A PE2007001122A PE20080425A1 PE 20080425 A1 PE20080425 A1 PE 20080425A1 PE 2007001122 A PE2007001122 A PE 2007001122A PE 2007001122 A PE2007001122 A PE 2007001122A PE 20080425 A1 PE20080425 A1 PE 20080425A1
- Authority
- PE
- Peru
- Prior art keywords
- beta
- alkyl
- agonists
- inhalation
- aerosol formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940125388 beta agonist Drugs 0.000 title abstract 2
- 239000000443 aerosol Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN BETA-AGONISTA DE FORMULA (1) DONDE R1 Y R2 SON CADA UNO H, HALOGENO, ALQUILO(C1-C4) O JUNTOS FORMAN ALQUILENO(C1-C6); R3 ES H, HALOGENO, OH, ALQUILO(C1-C4) U O-ALQUILO; X- ES UN ANION TAL COMO CLORURO, BROMURO, SULFATO, ACETATO, ENTRE OTROS; B) CLORURO DE BENZALCONIO EN UNA CANTIDAD DE 1 A 50MG POR 100ML DE SOLUCION; C) UN FORMADOR DE COMPLEJOS EN UNA CANTIDAD DE 1 A 50MG POR 100ML DE SOLUCION; D) UN DISOLVENTE TAL COMO AGUA, ETANOL O UNA MEZCLA DE LOS MISMOS EN DONDE EL ETANOL SE ENCUENTRA DE 5% A 99%; E) UN ANTIOXIDANTE TAL COMO ACIDO ASCORBICO, PROPILGALATO, ENTRE OTROS. DICHA COMPOSICION TIENE UN pH DE 2,5 A 6,5 SIENDO UTIL PARA EL TRATAMIENTO DE ENFISEMA PULMONAR, ASMA, FIBROSIS QUISTICA, BRONQUITIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06119274 | 2006-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080425A1 true PE20080425A1 (es) | 2008-06-16 |
Family
ID=38564599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001122A PE20080425A1 (es) | 2006-08-22 | 2007-08-20 | Formulacion aerosol para la inhalacion de beta-agonistas |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080053430A1 (es) |
| EP (1) | EP2056837A1 (es) |
| JP (1) | JP2010501523A (es) |
| AR (1) | AR062477A1 (es) |
| CA (1) | CA2661442A1 (es) |
| PE (1) | PE20080425A1 (es) |
| TW (1) | TW200820974A (es) |
| UY (1) | UY30555A1 (es) |
| WO (1) | WO2008023005A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| UY30550A1 (es) * | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos |
| EP2093219A1 (de) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
| AU2010229934A1 (en) * | 2009-03-24 | 2011-09-29 | Chevron U.S.A. Inc. | A system and method for characterizing fractures in a subsurface reservoir |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3026534A1 (de) * | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| UY30550A1 (es) * | 2006-08-22 | 2008-03-31 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos |
-
2007
- 2007-08-20 PE PE2007001122A patent/PE20080425A1/es not_active Application Discontinuation
- 2007-08-21 CA CA002661442A patent/CA2661442A1/en not_active Abandoned
- 2007-08-21 JP JP2009525053A patent/JP2010501523A/ja active Pending
- 2007-08-21 UY UY30555A patent/UY30555A1/es not_active Application Discontinuation
- 2007-08-21 US US11/842,472 patent/US20080053430A1/en not_active Abandoned
- 2007-08-21 WO PCT/EP2007/058655 patent/WO2008023005A1/de not_active Ceased
- 2007-08-21 EP EP07802747A patent/EP2056837A1/de not_active Withdrawn
- 2007-08-21 TW TW096130913A patent/TW200820974A/zh unknown
- 2007-08-22 AR ARP070103722A patent/AR062477A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010501523A (ja) | 2010-01-21 |
| CA2661442A1 (en) | 2008-02-28 |
| WO2008023005A1 (de) | 2008-02-28 |
| UY30555A1 (es) | 2008-03-31 |
| EP2056837A1 (de) | 2009-05-13 |
| AR062477A1 (es) | 2008-11-12 |
| US20080053430A1 (en) | 2008-03-06 |
| TW200820974A (en) | 2008-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080425A1 (es) | Formulacion aerosol para la inhalacion de beta-agonistas | |
| ES2579936T3 (es) | Nuevos lípidos catiónicos con diversos grupos de cabeza para el suministro oligonucleotídico | |
| MEP51008A (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| PE20120023A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
| AR050902A1 (es) | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion | |
| AR062104A1 (es) | Derivados de quinuclidina como antagonistas de m3 | |
| HRP20171614T1 (hr) | Heterociklički spojevi, lijekovi koji sadrže te spojeve, njihova primjena i postupci za njihovu proizvodnju | |
| PE20030827A1 (es) | Formulaciones hfa de agonistas beta-2 de derivados de 2(1h)-quinolinona de accion prolongada | |
| UY29840A1 (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| NZ721662A (en) | Amine and amine oxide surfactants for controlling herbicide spray drift | |
| JP2016527220A5 (es) | ||
| BR0107934A (pt) | Carboxamidas de pirimidina úteis como inibidores de isozimas pde4 | |
| CL2008001982A1 (es) | Acido (2s)-2-{[3´-cloro-4´-[2,2-dimetilpirrolidin-1-il) carbonil]-5-fluorobifenil-2-il]oxi}propanoico y su sal 2-metilpropan-2-amina; formas cristalinas de la sal y del acido libre; compuestos intermediarios; y uso en el tratamiento de asma, rinitis y enfermedad pulmonar obstructiva cronica. | |
| NO20054839L (no) | Formulering for en oppmalt-dose inhalator ved anvendelse av hydro-fluor-alkaner som drivmidler | |
| BR112014009087A2 (pt) | formulações de etanercept estabilizadas com xilitol | |
| NO20071196L (no) | Rengjoringssammensetninger for mikroelektroniske substrater | |
| AR063854A1 (es) | Beta-1,6-disacaridos de glucosamina funcionalizados y un procedimiento para su preparacion. composiciones farmaceuticas | |
| NO20062877L (no) | Stabile liposomsammensetninger som omfatter lipofile aminholdige farmasoytiske midler | |
| CN109851529A (zh) | 一种两性型含氟表面活性剂及其制备方法与应用 | |
| PE20061162A1 (es) | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos | |
| PE20050250A1 (es) | Antagonistas de los receptores muscarinicos de la acetilcolina | |
| PE20061437A1 (es) | Composicion en emulsion que comprende derivados de cicloalqueno, estable en rango acido | |
| AR059368A1 (es) | Composiciones acondicionadoras de telas | |
| PE20060311A1 (es) | Formulacion en aerosol para la inhalacion de beta-agonistas | |
| AR046114A1 (es) | Compuesto de 8- azoniabiciclo (3.2.1) octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |